MR in identifying incidentaloma is discussed in Chapter 6, and the seventh chapter discusses the study of adrenal glands in nuclear medicine. In this contribution, either consolidated or more experimental radiopharmaceuticals are presented, including those used for PET/CT, such as I-MIBG for therapy of pheochromocytomas. Chapter 8 defines the role of US and MR, respectively, as first-and second-line methods in related endocrine disorders in gonadal disorders. The following chapters dwell on the importance of MR in differential diagnosis of sellar region lesions (Chapter 9), also considering the pros and cons in the use of intra-operative MR for the removal of pituitary adenomas (Chapter 10). Chapter 11 instead focuses on high-affinity radiotracers for dopamine D2 receptors and of radiolabeled somatostatin analogues in helping diagnosis and management of pituitary adenomas. The last chapter, the twelfth, deals with the topic of neuroendocrine tumors, describing the actually used imaging techniques and future prospects. In particular, it is well-explained how the major role of PET in these tumors is associated with 68 Ga-DOTA peptide somatostatin analogues more than with 18 F-FDG. All the chapters are accompanied by many pictures, in color and in black and white, all extensively commented on, from tables and explanatory graphs of the text content. The clear language, the conversational tone, as well as the wealth of images that correlate to each covered topic, make this publication appealing not only to endocrinologists, radiologists, nuclear physicians and internists, but also to primary care physicians frequently involved in the management of patients with endocrine disorders. The easy didactic structure together with the wide content create interest also for residents and students of medicine.
